Results 1 to 10 of about 174,641 (215)

The Suggestive Effect of Apo A, Apo B, and Apo A/Apo B on Erectile Dysfunction [PDF]

Journal of Sexual Medicine, 2021
ABSTRACTBackgroundErectile dysfunction (ED) is closely related to coronary heart disease (CHD). Apolipoprotein (Apo) A1, Apo B, and Apo A/Apo B are known to be predictive factors for CHD. They are not yet a definite laboratory marker for the diagnosis of ED in cardiology. Therefore, we investigated the association between Apo A1, Apo B, and Apo A/Apo B,
Dongjie Li
exaly   +3 more sources

Evaluating the relation between serum apolipoprotein B (apo B), apolipoprotein A (apo A) and apo B/apo A ratio with diabetic retinopathy in a sample of type 2 Egyptian diabetic patient

The Egyptian Journal of Internal Medicine, 2023
Background Diabetic retinopathy (DR) is a chronic progressive, ocular disease affecting the retinal microvasculature accompanied by hyperglycaemia and different situations related to diabetes mellitus (DM) such as hypertension (HTN).
Salwa Seddik Hosny, Merhan Samy Nasr, Moataz M. W. Abd Elfattah, Samar Helmy Abdel Dayem, Rana Hashem Ibrahim   +4 more
doaj   +2 more sources

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Biomedicines, 2022
In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim
Arrigo F. G. Cicero, Federica Fogacci, Giuseppe Derosa, Angela D’Angelo, Fulvio Ventura, Elisabetta Rizzoli, Sergio D’Addato, Claudio Borghi, on behalf of the Brisighella Heart Study Group   +8 more
doaj   +2 more sources

The ins and outs of lipoprotein(a) assay methods

Archives of Medical Science: Atherosclerotic Diseases, 2023
Pathophysiological, epidemiological and genetic studies convincingly showed lipoprotein(a) (Lp(a)) to be a causal mediator of atherosclerotic cardiovascular disease (ASCVD).
Maryam Heydari, Majid Rezayi, Massimiliano Ruscica, Tannaz Jamialahmadi, Thomas P. Johnston, Amirhossein Sahebkar   +5 more
doaj   +1 more source

Association of Glycated Haemoglobin and Serum Apolipoproteins with Diabetic Retinopathy: An Indian Overview [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: India is presently facing an epidemic of diabetes mellitus and the risks of chronic complications from the disease are associated with the duration of the disease as well as the degree of hyperglycaemia.
Bhasker Mukherjee, Sandeep Shankar, Rehan Ahmed, Kanchan Singh, Kapil Bhatia   +4 more
doaj   +1 more source

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction

Frontiers in Cardiovascular Medicine, 2022
Background and AimsCurrent evidence suggests that lipoprotein(a) [Lp(a)] level above 50 mg/dL is associated with increased cardiovascular risk.
Olga I. Afanasieva, Marat V. Ezhov, Narek A. Tmoyan, Oksana A. Razova, Marina I. Afanasieva, Yuri G. Matchin, Sergei N. Pokrovsky   +6 more
doaj   +1 more source

Serum apolipoprotein B/apolipoprotein A1 ratio in relation to intervertebral disk herniation: a cross-sectional frequency-matched case–control study

Lipids in Health and Disease, 2021
Study design This was a cross-sectional frequency-matched case–control study. Background and aim The serum lipid profile of lipoprotein(a) [Lp(a)] level and apolipoprotein B/apolipoprotein A1 ratio (Apo B/Apo A1) ratio were found to be more ...
Fei Chen, Tongde Wu, Chong Bai, Song Guo, Wenjun Huang, Yaqin Pan, Huiying Zhang, Desheng Wu, Qiang Fu, Qi Chen, Xinhua Li, Lijun Li   +11 more
doaj   +1 more source

Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: Apo B and Apo A-I, are structural and functional components of lipoprotein particles that serve as transporters of cholesterol. The apo B/apo A-I ratio reflects the cholesterol transport and has been shown to be strongly related to risk ...
Hem Kumar Tamang, Uddhav Timilsina, Khelanand Prasad Singh, Sanjit Shrestha, Ramendra Kumar Raman, Pujan Panta, Preeti Karna, Laxmi Khadka, Chandika Dahal   +8 more
doaj   +1 more source

Studies on the apoproteins of rat lymph chylomicrons: characterization and metabolism of a new chylomicron-associated apoprotein

Journal of Lipid Research, 1981
The apoprotein composition of rat lymph chylomicrons and very low density lipoprotein (VLDL) was investigated following isolation and purification by preparative gel electrophoresis. The medium molecular weight apoproteins in the 27,000-60,000 range were
N H Fidge, P J McCullagh
doaj   +1 more source

A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping

Journal of Lipid Research, 1999
Apolipoprotein[a] phenotyping is a critically important method to explore the role of kringle-4 repeat number as a modulator of lipoprotein[a]-associated cardiovascular risk.
E. Anglés-Cano, S. Loyau, G. Cardoso-Saldaña, R. Couderc, P. Gillery   +4 more
doaj   +1 more source